MENU
CRDL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cardiol Therapeutics (CRDL) Earnings Date & Reports
Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease... Show more
A.I. Advisor
published Earnings
CRDL is expected to report earnings to rise 75.21% to -6 cents per share on November 12
Q3'26
Est.
$-0.06
Q2'26
Beat
by $0.03
Q1'26
Est.
$-0.07
Q4'25
Beat
by $0.03
Q3'25
Missed
by $0.01
The last earnings report on August 13 showed earnings per share of -3 cents, beating the estimate of -6 cents. With 387.55K shares outstanding, the current market capitalization sits at 205.16M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
How to use the MACD in trading?
How Does Capital Gains Tax Work? A Comprehensive Deep Dive
Tickeron Unveils TSM/SOXS Double Agent Trading Robot for Enhanced Market Performance
Overcoming Market Challenges: The Power of Tickeron’s Best AI Robots
Tickeron Launches Price Action Trading Bots for High-Liquidity Stocks
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsGeneric
Industry
N/A
Address
2265 Upper Middle Road East
Phone
+1 289 910-0850
Employees
23
Web
https://www.cardiolrx.com